Keyphrases
Prospective Cohort Study
100%
Hemodialysis Patients
100%
Survival Benefit
100%
Coronavirus Disease 2019 Vaccine
100%
Third Dose
100%
All-cause Mortality
66%
Antibody Level
50%
Domain Antibody
50%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
50%
Anti-spike
50%
Fully Vaccinated
50%
Spike Receptor Binding Domain
50%
Low Risk
33%
Dominant Period
33%
Confidence Interval
16%
Adjusted Hazard Ratio
16%
Vaccination
16%
Mortality Risk
16%
Effective Strategies
16%
Risk Response
16%
Decreased Risk
16%
Comorbid Conditions
16%
Humoral Response
16%
Patients Included
16%
Hospital-based Cohort
16%
Severe Coronavirus Disease 2019
16%
Revaccination
16%
Timely Vaccination
16%
Immunocompromised State
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
Hemodialysis
100%
Coronavirinae
100%
Diseases
100%
All Cause Mortality
66%
Infection
50%
Receptor Protein
50%
SARS Coronavirus
50%
Cohort Study
16%
Biochemistry, Genetics and Molecular Biology
Prospective Cohort Study
100%
Hemodialysis
100%
Coronavirinae
100%
All Cause Mortality
66%
Binding Domain
50%
Spike
50%
SARS Coronavirus
50%
Receptor Binding
50%
Cohort Study
16%
Humoral Immunity
16%